Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-London's FTSE 100 gains on hopes of stimulus, trade resolution

Wed, 11th Sep 2019 09:23

* FTSE 100 up 0.6%, FTSE 250 up 0.7%

* Financials, miners lead gains

* GMS drops after delaying results
(Adds company news items, analyst comment, updates share moves)

By Muvija M and Shashwat Awasthi

Sept 11 (Reuters) - UK blue-chips edged higher on Wednesday,
buoyed by hopes of monetary stimulus from central banks as
economic growth slows because of a protracted U.S.-China trade
war, while signs of a thaw in the dispute provided some relief
to investors.

The FTSE 100 was 0.6% higher by 0756 GMT, while the
midcap index rose 0.7%.

Asia-facing financials and mining heavyweights
were powering gains for the main bourse after a report said
China will introduce important measures to ease the negative
impact of the trade war with United States.

The European Central Bank is widely expected to cut interest
rates in this week's policy meeting, while the U.S. Federal
Reserve is seen following suit next week as a stretch of weak
economic data have stoked fears of a recession.

"I wonder whether investors have positioned themselves to be
disappointed," Oanda analyst Craig Erlam said in relation to
some aspects of an expected stimulus plan from the ECB.

Some news working in favour of multinational stocks was a
move from China to exempt 16 types of U.S. products from
additional retaliatory tariffs.

Consumer goods giant Unilever and the world's
biggest spirits company Diageo, which pocket a major
chunk of their earnings in U.S. dollars, inched down as sterling
rose ahead of a speech from opposition party deputy leader Tom
Watson.

He is expected to demand that the Labour Party campaign
against Brexit and push for a referendum to reverse the planned
departure before any election.

While weakness in the pound helped the main index notch
back-to-back gains in June and July, the local currency has
recovered in recent weeks as parliament took steps to prevent a
chaotic no-deal Brexit.

In results-driven gains, Galliford Try, which this
week said it has restarted talks to sell its housing units to
Bovis Homes, rose 2.1% after reporting strong margins at
Linden Homes despite Brexit-induced weakness in the market.

Smaller companies recorded some sharp moves, with Capital &
Regional jumping 7% after the company said Growthpoint
Properties was in talks to buy a majority stake, and Gulf Marine
Services plunging 12.6% to a life low after delaying
results.

Pharma services provider Consort Medical fell 4.2%
after saying it expected a bigger-than-expected hit to its
annual operating profit from a chemical incident at its
Cramlington facility.
(Reporting by Muvija M and Shashwat Awasthi in Bengaluru;
Editing by Arun Koyyur, Bernard Orr)

More News
3 Jan 2017 08:10

Consort Medical splutters as BAT stubs out Voke programme

(ShareCast News) - British American Tobacco has terminated an agreement with Consort Medical over the manufacture of nicotine inhalers for its Voke development programme. Consort, which said it was in "constructive dialogue" with BAT's Nicovations arm and product developer Kind Consumer over the fut

Read more
6 Dec 2016 08:18

Consort Medical posts good growth in first half

(ShareCast News) - Single source drug and delivery device company Consort Medical announced its interim results for the six months to 31 October on Tuesday. The London-listed firm said group revenue increased to £144.9m from £135.5m, representing underlying growth of 2.0% and reported growth of 6.9%

Read more
25 Nov 2016 09:07

Consort Medical appoints new CFO

(ShareCast News) - Consort Medical, a global provider of manufacturing solutions for drugs, announced that it has appointed Paul Hayes as group Finance Director of the Vitec Group. Hayes is taking over the position of chief financial officer from Richard Cotton as well joining the board as executive

Read more
27 Oct 2016 07:45

Consort Medical Welcomes Cimzia Autoclicks Launch On NHS

Read more
14 Oct 2016 12:23

Consort Medical's Bespak inks new agreement

(ShareCast News) - Consort medical, a global single source drug and Delivery device company (CDMO), has announced that its Bespak division has entered into an agreement with a biopharmaceutical company. Bespak manufactures drug delivery devices for pharmaceutical partner companies including respirat

Read more
19 Sep 2016 09:07

Consort Notes European Nod For Bespak Technology-Using Product

Read more
7 Sep 2016 08:43

Consort Medical signs agreement with AstraZeneca

(ShareCast News) - Consort medical, a provider of advanced technology for drugs, has signed a new contract with pharmaceutical giant AstraZeneca for the supply of its Bespak respiratory devices. AstraZeneca and Bespak have agreed to enter into a multi-year agreement for the scale-up and supply of Be

Read more
7 Sep 2016 07:03

Consort Medical Sees Little Brexit Impact; Signs Deal With AstraZeneca

Read more
23 Jun 2016 15:19

Director dealings: Derwent London CEO sells just ahead of Brexit vote

(ShareCast News) - Derwent London chief executive John Burns has sold £1.5m of the FTSE 250 real estate investor's shares in the week just before the EU referendum which could seriously lift or undermine the company's shares. In Wednesday's sale, which comes two days before results for Britain's ref

Read more
17 Jun 2016 09:29

Numis places Consort Medical 'under review'

(ShareCast News) - Consort Medical's shares were put 'under review' by Numis after the company reported its full year results. The pharmaceutical device frim on Thursday reported full year earnings before interest and tax rose 47.6% to £37m as revenues gained 49.8% to £276.9m, driven by a strong per

Read more
16 Jun 2016 14:52

Consort Medical's annual revenues rise as a product launch is delayed

(ShareCast News) - Consort Medical, a pharmaceutical device company, revealed higher full year profits on Thursday due to organic growth and an acquisition. Revenues rose 49.8% to £276.9m from £184.8m the previous financial year. Bespak, the company's drug device manufacturing subsidiary, continued

Read more
16 Jun 2016 07:37

Consort Medical Profit Doubles As Progress Made On DEV610 Programme

Read more
9 Jun 2016 15:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
22 Feb 2016 16:51

Consort Medical agrees partnership and invests in Precision Ocular

(ShareCast News) - Consort Medical has made a £3.3m equity investment for a 13.7% stake in retinal therapeutics specialist Precision Ocular and agreed a development and manufacturing partnership. London-based Precision Ocular has developed retinal treatments that are designed to access specific sma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.